Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
1,897.00
-19.70 (-1.03%)
Sep 11, 2026, 3:29 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 318.92 billion as of September 11, 2026. Its market cap has increased by 18.41% in one year.
Market Cap
318.92B
Enterprise Value
307.93B
Revenue
28.91B
Ranking
n/a
PE Ratio
58.92
Stock Price
1,897.00
ChartMarket Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 318.92B, an increase of 367.75%. That is a compound annual growth rate of 15.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 318.92B | 28.73% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.47T |
| Divi's Laboratories | 2.51T |
| Apollo Hospitals Enterprise | 1.28T |
| Lenskart Solutions | 1.21T |
| Emcure Pharmaceuticals | 372.30B |
| Wockhardt | 360.83B |
| Sai Life Sciences | 337.50B |
| Krishna Institute of Medical Sciences | 309.23B |